This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Dr. Kumiko Ui-Tei, PhD
Institute of Science Tokyo における CTO, ANRis Therapeutics and Director/Professor NucleoTIDE & PepTIDE Drug Discovery Center
スピーカー

アジェンダセッション

  • Precision-Engineered SNPD-siRNAs for Allele-Specific Silencing of Disease-Causing Mutations

    1:45pm